2002
DOI: 10.1016/s0304-4165(02)00369-0
|View full text |Cite
|
Sign up to set email alerts
|

Characterization of the O-GlcNAc protein modification in Xenopus laevis oocyte during oogenesis and progesterone-stimulated maturation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

2
30
0

Year Published

2005
2005
2019
2019

Publication Types

Select...
9
1

Relationship

3
7

Authors

Journals

citations
Cited by 35 publications
(32 citation statements)
references
References 44 publications
2
30
0
Order By: Relevance
“…Microinjection of galactosyltransferase an enzyme that caps terminal N-acetyL-glucosamine preventing OGA removal of the sugar moiety induces maturation defects causing mitotic checkpoint activation and cell death. 9 Oocytes treated with OGA inhibitor PUGNAc failed to mature properly, 10 while microinjection of GlcNAc impaired maturation and spindle formation. 11 Additionally, inhibition of OGT blocks the G 2 /M transition during maturation, 12 but microinjection of OGT promotes entry into M phase.…”
Section: Introductionmentioning
confidence: 98%
“…Microinjection of galactosyltransferase an enzyme that caps terminal N-acetyL-glucosamine preventing OGA removal of the sugar moiety induces maturation defects causing mitotic checkpoint activation and cell death. 9 Oocytes treated with OGA inhibitor PUGNAc failed to mature properly, 10 while microinjection of GlcNAc impaired maturation and spindle formation. 11 Additionally, inhibition of OGT blocks the G 2 /M transition during maturation, 12 but microinjection of OGT promotes entry into M phase.…”
Section: Introductionmentioning
confidence: 98%
“…The following observations support the notion that OGlcNAc is a regulatory post-translational modification analogous to protein phosphorylation: 1) O-GlcNAc is not further extended into more complex oligo-or polysaccharides with the exception of plant nuclear pore proteins (62,162); 2) the half-life of the O-GlcNAc modification is shorter that that of the protein it modifies (38,86,144); 3) O-GlcNAc levels respond dynamically to both extracellular (e.g., insulin) and intracellular (e.g., stress) stimuli (12,13,22,38,53,74,91,118,153,188,195); 4) sites of O-GlcNAc modification are similar to those used by protein kinases and are identical to those used by kinases on a subset of proteins (57); 5) OGlcNAc is essential for life in mammals, arabidopsis and drosophila (45,59,131,146,149), and the deletion of the O-GlcNAc transferase (OGT) is lethal in mice [embryonic day (E) 4.5] cells and some tissues (131,146); and 6) numerous studies have implicated O-GlcNAc in regulating enzyme activity, DNA binding, protein binding, localization, half-life, and regulating phosphorylation levels either by regulating protein kinases or by blocking amino acids that would otherwise be phosphorylated (58). For a subset of proteins, OGlcNAc can block phosphorylation either by modifying the same Ser/Thr residue that would usually be modified (e.g., C-Myc, Thr 58) (23,24), or sterically by modifying a nearby Ser/Thr residue (e.g., casein kinase 2, Ser347).…”
Section: Introductionmentioning
confidence: 99%
“…Both OGT and O-GlcNAcase have been found in complexes with phosphatases and kinases, suggesting that the exchange between phosphorylation and GlcNAcylation is rapid and dynamic (21,(25)(26)(27). Similar to phosphorylation, O-GlcNAc is dynamically added and removed in response to numerous extracellular signals, including: extracellular glucose concentration (28 -30), cell cycle (31), development (32,33), hormones such as insulin (34,35), phorbol esters (36), and the focus of this study, cellular stress (37).…”
mentioning
confidence: 98%